Rehabilitation Recommendations for Multiple Sclerosis Patients during the COVID-19 Pandemic

Abdorreza Naser Moghadasi ¹ , Mohaddeseh Azadvari ^1,2 * , Mohammad Ali Sahraian ¹

Cited by CrossRef: 5

1- SAHİN Ş. Management of Neurorehabilitation During the COVID-19 Pandemic. 2020;22(Special Issue):10 [Crossref]

2- Negm A, Salopek A, Zaide M, Meng V, Prada C, Chang Y, Zanwar P, Santos F, Philippou E, Rosario E, Faieta J, Falvey J, Kumar A, Reistetter T, Dal Bello-Haas V, Bean J, Bhandari M, Heyn P. Rehabilitation Care at the Time of Coronavirus Disease-19 (COVID-19) Pandemic: A Scoping Review of Health System Recommendations. Front Aging Neurosci. 2022;13 [Crossref]

3- Novotná K, Menkyová I, Kubala Havrdová E. Rehabilitation in post-Covid-19 patients (specifically those with multiple sclerosis). Neurol pro Praxi. 2022;23(1):84 [Crossref]

4- Esmaeili S, Abbasi M, Abolmaali M, Mojtahed M, Alavi S, Soleimani S, Mokhtari M, Hatam J, Khotbehsara S, Motamed M, Joghataei M, Mirzaasgari Z, Moghaddasi M. Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD. BMC Neurol. 2021;21(1) [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.